Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mucocutaneous Lymph Node Syndrome | 43 | 2023 | 539 | 4.550 |
Why?
|
Rheumatology | 14 | 2022 | 617 | 1.640 |
Why?
|
Coronary Aneurysm | 13 | 2023 | 234 | 1.610 |
Why?
|
Immunoglobulins, Intravenous | 20 | 2022 | 667 | 1.340 |
Why?
|
Vasculitis | 7 | 2016 | 525 | 1.200 |
Why?
|
Lyme Disease | 9 | 2021 | 630 | 1.130 |
Why?
|
Immunosuppressive Agents | 13 | 2022 | 4206 | 0.770 |
Why?
|
Dermatomyositis | 5 | 2024 | 259 | 0.740 |
Why?
|
Macrophage Activation Syndrome | 5 | 2023 | 124 | 0.730 |
Why?
|
Evidence-Based Medicine | 12 | 2022 | 3706 | 0.680 |
Why?
|
Glucocorticoids | 8 | 2021 | 2167 | 0.670 |
Why?
|
Antirheumatic Agents | 9 | 2021 | 1381 | 0.660 |
Why?
|
Methylprednisolone | 5 | 2018 | 386 | 0.550 |
Why?
|
Immunologic Factors | 5 | 2015 | 1596 | 0.550 |
Why?
|
Adrenal Cortex Hormones | 3 | 2020 | 1886 | 0.480 |
Why?
|
Child, Preschool | 58 | 2023 | 42669 | 0.450 |
Why?
|
Child | 70 | 2024 | 80917 | 0.430 |
Why?
|
Rheumatic Diseases | 3 | 2016 | 659 | 0.410 |
Why?
|
Immunoglobulin A | 1 | 2016 | 992 | 0.410 |
Why?
|
Decision Support Techniques | 5 | 2021 | 2008 | 0.410 |
Why?
|
Polyarteritis Nodosa | 3 | 2021 | 70 | 0.410 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 3 | 2022 | 271 | 0.400 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 4 | 2021 | 297 | 0.390 |
Why?
|
Mucopolysaccharidoses | 1 | 2011 | 27 | 0.390 |
Why?
|
Collagen Diseases | 1 | 2011 | 39 | 0.390 |
Why?
|
Takayasu Arteritis | 3 | 2021 | 106 | 0.380 |
Why?
|
Cyclophosphamide | 5 | 2021 | 2227 | 0.350 |
Why?
|
Mycophenolic Acid | 1 | 2012 | 348 | 0.350 |
Why?
|
Receptors, Tumor Necrosis Factor | 3 | 2014 | 587 | 0.330 |
Why?
|
Osteomyelitis | 2 | 2012 | 408 | 0.330 |
Why?
|
Arthritis, Infectious | 4 | 2011 | 348 | 0.330 |
Why?
|
Systemic Vasculitis | 1 | 2009 | 37 | 0.330 |
Why?
|
Anti-Inflammatory Agents | 6 | 2014 | 1805 | 0.310 |
Why?
|
Lupus Nephritis | 1 | 2012 | 327 | 0.310 |
Why?
|
Hospitalization | 4 | 2016 | 10840 | 0.290 |
Why?
|
Drug Therapy, Combination | 12 | 2021 | 6316 | 0.290 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2 | 2021 | 238 | 0.290 |
Why?
|
Giant Cell Arteritis | 2 | 2021 | 307 | 0.280 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2023 | 621 | 0.270 |
Why?
|
Adenosine Deaminase | 2 | 2019 | 253 | 0.270 |
Why?
|
Coronary Vessels | 6 | 2017 | 3124 | 0.270 |
Why?
|
Methotrexate | 5 | 2017 | 1721 | 0.260 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 4 | 2016 | 2271 | 0.250 |
Why?
|
Heart Diseases | 2 | 2016 | 2819 | 0.250 |
Why?
|
Autoimmune Diseases | 4 | 2008 | 2257 | 0.250 |
Why?
|
Infant | 32 | 2021 | 36535 | 0.250 |
Why?
|
Musculoskeletal Diseases | 2 | 2010 | 599 | 0.250 |
Why?
|
Pediatrics | 3 | 2017 | 3629 | 0.240 |
Why?
|
Knee Joint | 2 | 2021 | 1683 | 0.240 |
Why?
|
Adolescent | 39 | 2022 | 89169 | 0.230 |
Why?
|
Neurology | 3 | 2021 | 786 | 0.230 |
Why?
|
Prednisolone | 3 | 2018 | 326 | 0.230 |
Why?
|
Humans | 108 | 2024 | 768166 | 0.220 |
Why?
|
Antibodies, Monoclonal | 5 | 2010 | 9263 | 0.220 |
Why?
|
Chest Pain | 1 | 2010 | 1101 | 0.220 |
Why?
|
Raynaud Disease | 2 | 2006 | 81 | 0.220 |
Why?
|
Immunoglobulin G | 4 | 2014 | 4568 | 0.220 |
Why?
|
Vascular Diseases | 1 | 2011 | 1162 | 0.210 |
Why?
|
Synovial Fluid | 3 | 2021 | 393 | 0.210 |
Why?
|
Anti-Infective Agents | 1 | 2010 | 983 | 0.200 |
Why?
|
Software | 1 | 2016 | 4478 | 0.200 |
Why?
|
Communicable Diseases | 2 | 2021 | 874 | 0.200 |
Why?
|
Leukocytosis | 1 | 2003 | 251 | 0.200 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2019 | 1656 | 0.190 |
Why?
|
Fever | 4 | 2023 | 1614 | 0.180 |
Why?
|
Erythema Chronicum Migrans | 1 | 2020 | 48 | 0.180 |
Why?
|
Arthritis, Psoriatic | 3 | 2008 | 219 | 0.180 |
Why?
|
Lyme Neuroborreliosis | 1 | 2020 | 50 | 0.170 |
Why?
|
Male | 61 | 2022 | 364719 | 0.170 |
Why?
|
Pain Measurement | 4 | 2022 | 3583 | 0.170 |
Why?
|
Interferon Type I | 1 | 2023 | 569 | 0.170 |
Why?
|
Female | 62 | 2022 | 397192 | 0.170 |
Why?
|
Eosinophilia | 2 | 2023 | 556 | 0.160 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2003 | 246 | 0.160 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 299 | 0.160 |
Why?
|
Neutropenia | 1 | 2003 | 892 | 0.150 |
Why?
|
Cell Polarity | 1 | 2021 | 639 | 0.150 |
Why?
|
Treatment Outcome | 20 | 2021 | 65371 | 0.150 |
Why?
|
Coronary Thrombosis | 2 | 2016 | 440 | 0.150 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2003 | 716 | 0.140 |
Why?
|
Amoxicillin | 1 | 1998 | 182 | 0.140 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 467 | 0.140 |
Why?
|
Agammaglobulinemia | 1 | 2018 | 174 | 0.140 |
Why?
|
Immunomodulation | 1 | 2020 | 549 | 0.130 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2021 | 3114 | 0.130 |
Why?
|
gamma-Globulins | 2 | 1993 | 119 | 0.130 |
Why?
|
Genetic Diseases, Inborn | 1 | 2001 | 606 | 0.130 |
Why?
|
Medication Therapy Management | 1 | 2017 | 131 | 0.130 |
Why?
|
Fever of Unknown Origin | 2 | 2009 | 94 | 0.130 |
Why?
|
United States | 17 | 2022 | 73039 | 0.130 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2018 | 235 | 0.130 |
Why?
|
Prednisone | 4 | 2012 | 1567 | 0.120 |
Why?
|
Penicillins | 1 | 1998 | 406 | 0.120 |
Why?
|
Hearing Loss, Sensorineural | 2 | 1992 | 783 | 0.120 |
Why?
|
Diagnosis, Differential | 7 | 2019 | 13014 | 0.120 |
Why?
|
Remission Induction | 4 | 2021 | 2410 | 0.120 |
Why?
|
Pericardiectomy | 1 | 2014 | 45 | 0.120 |
Why?
|
Central Nervous System Diseases | 1 | 2019 | 520 | 0.120 |
Why?
|
Pericardiocentesis | 1 | 2014 | 78 | 0.120 |
Why?
|
Echocardiography | 5 | 2019 | 5047 | 0.110 |
Why?
|
Consensus | 5 | 2021 | 3212 | 0.110 |
Why?
|
Calcinosis | 1 | 2002 | 1481 | 0.110 |
Why?
|
Biological Products | 1 | 2023 | 948 | 0.110 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2024 | 2171 | 0.110 |
Why?
|
Th17 Cells | 1 | 2020 | 791 | 0.110 |
Why?
|
Retrospective Studies | 18 | 2023 | 81762 | 0.110 |
Why?
|
Pericarditis | 1 | 2014 | 136 | 0.110 |
Why?
|
Myocarditis | 1 | 2020 | 802 | 0.100 |
Why?
|
Pain Perception | 1 | 2014 | 198 | 0.100 |
Why?
|
Lung Diseases | 1 | 2023 | 1944 | 0.100 |
Why?
|
Pericardial Effusion | 1 | 2014 | 246 | 0.100 |
Why?
|
Blood Sedimentation | 4 | 2019 | 236 | 0.100 |
Why?
|
South America | 1 | 2012 | 180 | 0.100 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2007 | 696 | 0.100 |
Why?
|
North America | 3 | 2021 | 1289 | 0.100 |
Why?
|
Societies, Medical | 2 | 2020 | 3968 | 0.100 |
Why?
|
Steroids | 1 | 2016 | 938 | 0.090 |
Why?
|
Somatoform Disorders | 1 | 2014 | 425 | 0.090 |
Why?
|
Autoantibodies | 4 | 2023 | 2121 | 0.090 |
Why?
|
Hip Joint | 2 | 2011 | 1018 | 0.090 |
Why?
|
Length of Stay | 4 | 2016 | 6498 | 0.090 |
Why?
|
Azathioprine | 1 | 2012 | 354 | 0.090 |
Why?
|
Asia | 1 | 2012 | 629 | 0.090 |
Why?
|
Practice Guidelines as Topic | 4 | 2020 | 7454 | 0.090 |
Why?
|
Arthralgia | 1 | 2014 | 459 | 0.090 |
Why?
|
Pain Threshold | 1 | 2014 | 607 | 0.090 |
Why?
|
Arthritis | 2 | 2008 | 684 | 0.090 |
Why?
|
Anti-Bacterial Agents | 5 | 2020 | 7477 | 0.090 |
Why?
|
Hippocratic Oath | 1 | 2009 | 16 | 0.080 |
Why?
|
Dilatation, Pathologic | 3 | 2010 | 527 | 0.080 |
Why?
|
Infusions, Intravenous | 3 | 2007 | 2230 | 0.080 |
Why?
|
Proteinuria | 1 | 2012 | 611 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1281 | 0.080 |
Why?
|
Myositis | 2 | 2005 | 269 | 0.080 |
Why?
|
Administration, Oral | 2 | 2012 | 4030 | 0.080 |
Why?
|
C-Reactive Protein | 4 | 2022 | 3858 | 0.080 |
Why?
|
Borrelia burgdorferi | 1 | 2010 | 183 | 0.080 |
Why?
|
Inflammation | 3 | 2022 | 10873 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 36743 | 0.070 |
Why?
|
Pain | 2 | 2021 | 5100 | 0.070 |
Why?
|
Aspirin | 5 | 2007 | 3135 | 0.070 |
Why?
|
Drug Administration Schedule | 3 | 2011 | 4860 | 0.070 |
Why?
|
Data Collection | 1 | 2016 | 3327 | 0.070 |
Why?
|
Rheumatic Fever | 1 | 2007 | 73 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3781 | 0.070 |
Why?
|
Minocycline | 1 | 2008 | 170 | 0.070 |
Why?
|
Creatinine | 1 | 2012 | 1918 | 0.070 |
Why?
|
Early Diagnosis | 1 | 2011 | 1194 | 0.070 |
Why?
|
Disease Management | 3 | 2021 | 2536 | 0.070 |
Why?
|
Muscle Weakness | 1 | 2009 | 412 | 0.070 |
Why?
|
Prognosis | 7 | 2021 | 30010 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2010 | 4352 | 0.060 |
Why?
|
Age Factors | 4 | 2019 | 18412 | 0.060 |
Why?
|
Double-Blind Method | 4 | 2014 | 12465 | 0.060 |
Why?
|
Europe | 1 | 2012 | 3436 | 0.060 |
Why?
|
Antibodies | 2 | 2023 | 2421 | 0.060 |
Why?
|
Age of Onset | 4 | 2024 | 3347 | 0.060 |
Why?
|
Risk Assessment | 5 | 2020 | 24315 | 0.060 |
Why?
|
Physical Examination | 1 | 2010 | 1263 | 0.060 |
Why?
|
Autoimmunity | 2 | 2008 | 1361 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2862 | 0.060 |
Why?
|
Clinical Protocols | 1 | 2010 | 1443 | 0.060 |
Why?
|
Infant, Newborn | 7 | 2016 | 26422 | 0.060 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2005 | 387 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10266 | 0.060 |
Why?
|
Longitudinal Studies | 3 | 2011 | 14783 | 0.060 |
Why?
|
Immunoglobulins | 1 | 2007 | 855 | 0.060 |
Why?
|
Coronary Artery Disease | 2 | 2018 | 6568 | 0.060 |
Why?
|
Injections, Intravenous | 2 | 1998 | 1377 | 0.050 |
Why?
|
Antibodies, Bacterial | 2 | 2020 | 1479 | 0.050 |
Why?
|
Coronary Disease | 2 | 1999 | 5919 | 0.050 |
Why?
|
Patient Discharge | 1 | 2016 | 3479 | 0.050 |
Why?
|
Reference Values | 3 | 2019 | 4938 | 0.050 |
Why?
|
Bronchitis | 1 | 2003 | 194 | 0.050 |
Why?
|
Interleukin-15 | 1 | 2023 | 186 | 0.050 |
Why?
|
Scleroderma, Systemic | 1 | 2006 | 346 | 0.050 |
Why?
|
Incidence | 2 | 2023 | 21538 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2011 | 39348 | 0.050 |
Why?
|
Glycosylation | 2 | 2018 | 1100 | 0.050 |
Why?
|
Proteomics | 3 | 2023 | 3912 | 0.050 |
Why?
|
Mixed Connective Tissue Disease | 1 | 2002 | 32 | 0.050 |
Why?
|
Plasmapheresis | 1 | 2002 | 206 | 0.050 |
Why?
|
HLA-DR Antigens | 1 | 2023 | 609 | 0.050 |
Why?
|
Time Factors | 7 | 2014 | 40218 | 0.050 |
Why?
|
Germ-Line Mutation | 2 | 2019 | 1885 | 0.050 |
Why?
|
B-Lymphocytes | 2 | 2023 | 4793 | 0.050 |
Why?
|
Administration, Cutaneous | 1 | 2024 | 716 | 0.050 |
Why?
|
Interleukin-4 | 1 | 2005 | 1156 | 0.050 |
Why?
|
Microscopic Polyangiitis | 1 | 2021 | 46 | 0.050 |
Why?
|
Insect Repellents | 1 | 2020 | 18 | 0.050 |
Why?
|
Acute Kidney Injury | 1 | 1993 | 1942 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10760 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7951 | 0.050 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2002 | 446 | 0.050 |
Why?
|
Case-Control Studies | 5 | 2021 | 22291 | 0.050 |
Why?
|
Sensation Disorders | 1 | 2002 | 160 | 0.050 |
Why?
|
Churg-Strauss Syndrome | 1 | 2021 | 75 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2003 | 13676 | 0.040 |
Why?
|
Infectious Disease Medicine | 1 | 2020 | 49 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 257 | 0.040 |
Why?
|
International Cooperation | 1 | 2006 | 1436 | 0.040 |
Why?
|
Odds Ratio | 1 | 2012 | 9669 | 0.040 |
Why?
|
Chronic Disease | 2 | 2012 | 9384 | 0.040 |
Why?
|
Chemokine CXCL9 | 1 | 2019 | 135 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15454 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2023 | 1252 | 0.040 |
Why?
|
Thalidomide | 1 | 2004 | 886 | 0.040 |
Why?
|
Risk Factors | 7 | 2023 | 74944 | 0.040 |
Why?
|
Prospective Studies | 4 | 2019 | 54926 | 0.040 |
Why?
|
Parvoviridae Infections | 1 | 1998 | 39 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4648 | 0.040 |
Why?
|
Borrelia burgdorferi Group | 1 | 1998 | 96 | 0.040 |
Why?
|
Parvovirus B19, Human | 1 | 1998 | 42 | 0.040 |
Why?
|
Serologic Tests | 1 | 2020 | 382 | 0.040 |
Why?
|
Analgesia, Epidural | 1 | 2002 | 332 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
Syndrome | 2 | 2002 | 3272 | 0.040 |
Why?
|
Fathers | 1 | 2001 | 377 | 0.040 |
Why?
|
Hepatitis, Viral, Human | 1 | 1998 | 141 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2019 | 251 | 0.040 |
Why?
|
Cohort Studies | 5 | 2014 | 41754 | 0.040 |
Why?
|
Movement Disorders | 1 | 2002 | 463 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2023 | 924 | 0.040 |
Why?
|
Coronary Vessel Anomalies | 1 | 2020 | 308 | 0.040 |
Why?
|
Young Adult | 5 | 2016 | 60066 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2023 | 977 | 0.040 |
Why?
|
Boston | 2 | 2021 | 9374 | 0.030 |
Why?
|
Ferritins | 1 | 2019 | 601 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2021 | 1864 | 0.030 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2020 | 881 | 0.030 |
Why?
|
Exanthema | 1 | 2001 | 503 | 0.030 |
Why?
|
Central Nervous System | 1 | 2024 | 1346 | 0.030 |
Why?
|
Th1 Cells | 1 | 2021 | 1042 | 0.030 |
Why?
|
Cytokines | 2 | 2023 | 7453 | 0.030 |
Why?
|
Sex Distribution | 2 | 2014 | 2278 | 0.030 |
Why?
|
Databases, Factual | 2 | 2014 | 8080 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2002 | 1273 | 0.030 |
Why?
|
Point Mutation | 1 | 2001 | 1596 | 0.030 |
Why?
|
Biological Therapy | 1 | 2017 | 140 | 0.030 |
Why?
|
Antibodies, Antinuclear | 2 | 2008 | 342 | 0.030 |
Why?
|
Education | 1 | 1999 | 533 | 0.030 |
Why?
|
Sarcoidosis | 1 | 2001 | 535 | 0.030 |
Why?
|
Age Distribution | 2 | 2014 | 2873 | 0.030 |
Why?
|
Ticlopidine | 1 | 2000 | 730 | 0.030 |
Why?
|
Antigens, CD | 2 | 2007 | 4035 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15948 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 1999 | 794 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2020 | 1183 | 0.030 |
Why?
|
California | 1 | 2019 | 1438 | 0.030 |
Why?
|
Aortic Diseases | 1 | 2001 | 741 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2001 | 1429 | 0.030 |
Why?
|
Disease Progression | 4 | 2019 | 13671 | 0.030 |
Why?
|
Sinusitis | 1 | 2003 | 997 | 0.030 |
Why?
|
Complement C1 Inactivator Proteins | 1 | 1994 | 89 | 0.030 |
Why?
|
Attitude to Health | 1 | 2003 | 2025 | 0.030 |
Why?
|
Skin Diseases | 1 | 2002 | 1085 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2009 | 4978 | 0.030 |
Why?
|
Random Allocation | 1 | 2018 | 2396 | 0.030 |
Why?
|
Aorta | 1 | 2001 | 2045 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2040 | 0.030 |
Why?
|
Sensory Thresholds | 1 | 2014 | 377 | 0.030 |
Why?
|
Physical Stimulation | 1 | 2014 | 517 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2001 | 4120 | 0.030 |
Why?
|
Child Behavior | 1 | 1998 | 864 | 0.030 |
Why?
|
Psoriasis | 1 | 2000 | 926 | 0.030 |
Why?
|
Bone Conduction | 1 | 1992 | 102 | 0.020 |
Why?
|
Fibroblasts | 1 | 2002 | 4176 | 0.020 |
Why?
|
Audiometry, Pure-Tone | 1 | 1992 | 210 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1751 | 0.020 |
Why?
|
Contractile Proteins | 1 | 2012 | 240 | 0.020 |
Why?
|
Adult | 9 | 2024 | 223646 | 0.020 |
Why?
|
Auditory Threshold | 1 | 1992 | 369 | 0.020 |
Why?
|
Metalloendopeptidases | 1 | 2012 | 386 | 0.020 |
Why?
|
Hepatomegaly | 1 | 2010 | 84 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 9538 | 0.020 |
Why?
|
Salicylates | 1 | 1991 | 128 | 0.020 |
Why?
|
Pilot Projects | 2 | 2022 | 8741 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3228 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2000 | 2080 | 0.020 |
Why?
|
Skin | 1 | 2024 | 4503 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2540 | 0.020 |
Why?
|
Hearing Tests | 1 | 1990 | 123 | 0.020 |
Why?
|
Health Status | 1 | 2003 | 4091 | 0.020 |
Why?
|
Drug Resistance | 1 | 1996 | 1599 | 0.020 |
Why?
|
Lung Diseases, Interstitial | 1 | 1998 | 940 | 0.020 |
Why?
|
Sex Factors | 2 | 2014 | 10632 | 0.020 |
Why?
|
Forecasting | 1 | 1999 | 2945 | 0.020 |
Why?
|
Blood Cell Count | 1 | 1990 | 406 | 0.020 |
Why?
|
Acute Disease | 4 | 2007 | 7243 | 0.020 |
Why?
|
Body Surface Area | 2 | 2001 | 205 | 0.020 |
Why?
|
Retreatment | 1 | 2010 | 598 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4415 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2016 | 1815 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2000 | 2763 | 0.020 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2008 | 72 | 0.020 |
Why?
|
Serum Albumin | 1 | 1991 | 677 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2011 | 1609 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2008 | 424 | 0.020 |
Why?
|
DNA | 1 | 2001 | 7214 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2012 | 1133 | 0.020 |
Why?
|
Pulse Therapy, Drug | 1 | 2007 | 37 | 0.020 |
Why?
|
Treatment Failure | 1 | 1993 | 2661 | 0.020 |
Why?
|
DNA Methylation | 1 | 2021 | 4428 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2014 | 1835 | 0.020 |
Why?
|
Chorea | 1 | 2007 | 80 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13290 | 0.020 |
Why?
|
Recurrence | 1 | 1998 | 8509 | 0.020 |
Why?
|
Databases as Topic | 1 | 2007 | 472 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2012 | 2202 | 0.020 |
Why?
|
Electrocardiography | 1 | 1998 | 6412 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10399 | 0.020 |
Why?
|
Algorithms | 2 | 2019 | 14164 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14729 | 0.010 |
Why?
|
Renal Dialysis | 1 | 1993 | 1791 | 0.010 |
Why?
|
Receptors, IgE | 1 | 2005 | 375 | 0.010 |
Why?
|
Quality Improvement | 1 | 2019 | 3857 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2005 | 18065 | 0.010 |
Why?
|
Inpatients | 1 | 2014 | 2566 | 0.010 |
Why?
|
Animals | 3 | 2021 | 169246 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13490 | 0.010 |
Why?
|
Seasons | 1 | 2007 | 1524 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 1995 | 3533 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20227 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3814 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 19015 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 1613 | 0.010 |
Why?
|
Social Adjustment | 1 | 2003 | 635 | 0.010 |
Why?
|
Patient Readmission | 1 | 2014 | 3288 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 2009 | 1876 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2006 | 2732 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 2005 | 1506 | 0.010 |
Why?
|
Cryptogenic Organizing Pneumonia | 1 | 1998 | 28 | 0.010 |
Why?
|
Dermatitis, Atopic | 1 | 2005 | 737 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15869 | 0.010 |
Why?
|
Benchmarking | 1 | 2003 | 1057 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 3390 | 0.010 |
Why?
|
Insurance, Health | 1 | 2007 | 2517 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26379 | 0.010 |
Why?
|
Family | 1 | 2005 | 3209 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2007 | 12077 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 22379 | 0.010 |
Why?
|
Neutrophils | 1 | 2007 | 3786 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 30238 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2007 | 5349 | 0.010 |
Why?
|
Orthopedic Procedures | 1 | 2003 | 1279 | 0.010 |
Why?
|
Angioedema | 1 | 1994 | 184 | 0.010 |
Why?
|
Survival Rate | 1 | 2006 | 12840 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2003 | 2663 | 0.010 |
Why?
|
Ultrafiltration | 1 | 1991 | 48 | 0.010 |
Why?
|
Macrophages | 1 | 2005 | 5799 | 0.010 |
Why?
|
Autoantigens | 1 | 1994 | 890 | 0.010 |
Why?
|
Carbon Radioisotopes | 1 | 1991 | 567 | 0.010 |
Why?
|
Phenotype | 1 | 2006 | 16726 | 0.000 |
Why?
|
Comorbidity | 1 | 2003 | 10590 | 0.000 |
Why?
|
Aging | 1 | 2007 | 8744 | 0.000 |
Why?
|
Epitopes | 1 | 1994 | 2528 | 0.000 |
Why?
|
Mice | 1 | 2012 | 82029 | 0.000 |
Why?
|
Ultrasonography | 1 | 1998 | 6004 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1994 | 13421 | 0.000 |
Why?
|
Peptides | 1 | 1994 | 4354 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1994 | 17622 | 0.000 |
Why?
|
Protein Binding | 1 | 1991 | 9343 | 0.000 |
Why?
|
Middle Aged | 1 | 2006 | 223492 | 0.000 |
Why?
|